Trials / Conditions / Patent Ductus Arteriosus (PDA)
Patent Ductus Arteriosus (PDA)
6 registered clinical trials studyying Patent Ductus Arteriosus (PDA) — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | PREEMIE: Study for Treatment of PDA in Premature Infants NCT06587282 | Merit Medical Systems, Inc. | N/A |
| Completed | Prophylactic IV Paracetamol in Extremely Premature Infants NCT07067177 | Al-Quds University | Phase 2 / Phase 3 |
| Not Yet Recruiting | Outcome of Transcatheter Closure of Patent Ductus Arteriosus in Pediatric Cardiology Unit in 3 Years Duration NCT06634407 | Assiut University | N/A |
| Terminated | Fenoldopam to Prevent Renal Dysfunction in Indomethacin Treated Preterm Infants NCT02620761 | Medical College of Wisconsin | Phase 2 / Phase 3 |
| Completed | Nit-Occlud PDA Post-Approval Study NCT02100683 | PFM Medical, Inc | — |
| Completed | Closure Of Patent Ductus Arteriosus With the AMPLATZER Duct Occluder the AMPLATZER® Duct Occluder NCT00583596 | Abbott Medical Devices | N/A |